Viiv Healthcare

This study tested two experimental oral drugs designed to block HIV by targeting the virus's capsid. It involved 44 adults with HIV who had never taken antiviral medication before. Participants received one of the drugs or a placebo for 10 days so researchers could measure how mu…

This study provided continued access to the HIV medication dolutegravir for children and adolescents who had successfully completed earlier clinical trials. It aimed to ensure these young patients could keep receiving their effective treatment until the drug became commercially a…

This study tested a simpler, two-drug HIV treatment in teenagers who had never taken HIV medication before. The goal was to see if taking fewer drugs could still effectively control the virus for up to three years while potentially reducing long-term side effects. Thirty-two adol…

This study tested different ways for clinics to offer a long-acting injection (called cabotegravir or Apretude) to prevent HIV. It involved 370 Black cisgender and transgender women without HIV, as well as clinic staff. The main goal was to see which clinic strategies worked best…

This study aimed to find the best ways for clinics to offer a long-acting injection for HIV prevention. It involved 287 HIV-negative men and transgender men, who received the shot, and clinic staff who administered it. Researchers compared two different support strategies for cli…

This early-stage study tested the safety and how the body processes two new long-acting injection formulations of cabotegravir, a medication used for HIV prevention. The study involved 56 healthy adult volunteers who received a single injection. Researchers monitored participants…

This was the first study in humans for a new drug called VH4524184, which is being developed for HIV. The main goal was to check if the drug is safe and to see how the body processes it. The study involved 84 healthy volunteers who received either the drug or a placebo, and resea…

This early study tested how a new HIV drug candidate behaves in healthy adults. Researchers examined how the body absorbs different tablet forms, whether food affects absorption, and how it interacts with other common medications. The study involved 126 healthy volunteers to gath…